4 Discussion In this preliminary, hypothesis-generating, prospective, double-blind, cross-over interventional study, we examined efficacy and mechanistic effects of a novel tear substitute containing 0.2% HA acid supplemented with 0.4% butyroyl-glutathione (i.e., GSH-C4) in patients with G-OSD
Epitalon Key features Tetrapeptide (AEDG) for in-vitro studies of telomere-related pathways and cellular ageing markers
Generally considered safe when taken in recommended doses
In response, the government has increasingly focused on managing these diseases through campaigns promoting healthier living
it has no biological function whatsoever
Most are small subcutaneous injections into fatty tissue, often in the abdomen or thigh